In this study, the authors finally hypothesized that S1R ability to remodel the lipid and protein composition of the lipid rafts might help cancer cells to stimulate oncogenic signaling pathways, and suggested that the use of S1R drugs could destabilize the rafts and help to better sensitize these cells to apoptotic agents. This evidence concerns the gene TMBIM4 and cancer.